TennesseeHB 2101114th General Assembly (2025-2026)House

AN ACT to amend Tennessee Code Annotated, Title 39, Chapter 17, Part 4, relative to drugs.

Sponsored By: Sponsor information unavailable

Signed by Governor

Drugs, Over the Counter

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

7 provisions identified: 1 benefits, 3 costs, 3 mixed.

Meth registry listings block medicine purchases

Beginning July 1, 2026, the Tennessee Bureau of Investigation must electronically report methamphetamine registry additions at least every seven days. Reports include each person's full name, birth date, and driver's license or other ID number. The tracking system must issue alerts blocking covered purchases by people listed under the state's meth registry law. The bureau must also report removals from the registry. After that notice, the system must remove the person so they can again buy nonexempt products.

Fewer pharmacist checks on medicine purchases

Beginning July 1, 2026, pharmacists and pharmacy interns no longer must counsel buyers about why they need these products. The law also removes this provision's authority to refuse sales based on doubts about a legitimate medical purpose. Other sales restrictions remain in place.

Existing rules reach pharmacist-written medicine orders

Beginning July 1, 2026, existing state requirements for these products also cover prescription orders written by pharmacists. This applies to pharmacist-generated orders authorized by Tennessee Code Annotated § 63-10-206. The extension concerns the requirements in § 39-17-431(c), not every rule governing over-the-counter sales.

Stricter rules for remote medicine buyers

Beginning July 1, 2026, online and remote buyers of ephedrine or pseudoephedrine products must provide government-issued identification. Sellers must verify the buyer's name, ID number, and residential address through the electronic tracking system. Before completing a sale, sellers must check daily, 30-day, and yearly purchase limits and block purchases exceeding them. Delivery is allowed only to the residential address on the ID. Post office boxes, commercial mail receiving agencies, and other addresses are not allowed.

Medicine manufacturers pay new tracking fees

Beginning January 1, 2027, manufacturers of ephedrine or pseudoephedrine products sold in or into Tennessee must pay monthly tracking fees. The tracking system administrator sets fee amounts each year; the law sets no specific amount. Annual increases of 10% or more require proof that they directly reflect system administration costs. Those costs include labor, services, and materials.

Free pharmacy tracking with data safeguards

Beginning July 1, 2026, the law updates pharmacy sales tracking requirements dating to January 1, 2012. Pharmacies must record covered over-the-counter ephedrine and pseudoephedrine sales before completing them and correct known entry errors. System alerts block sales, subject to the law's stop-sale exception; these tracking requirements do not cover valid prescriptions. Only law enforcement officials, healthcare professionals, and pharmacists may use the data, solely to control sales of methamphetamine precursors. The system and required equipment are free to pharmacies. If the main system becomes unavailable, including loss of free access, pharmacies must use the Tennessee Methamphetamine Information System. They must switch once free equipment is available; the backup system is also free.

Pharmacies gain limited protection from lawsuits

Beginning July 1, 2026, pharmacies following the electronic tracking rules gain protection from civil claims over those duties. This limits some claims by customers and third parties. Protection does not cover negligence, wantonness, recklessness, or deliberate misconduct. Third-party protection does not apply when the retailer violated the tracking rules in connection with the claim. These protections do not apply to purchases under a valid prescription.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

  • Renea Jones

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 170 • No: 0

Senate vote • 4/9/2026

FLOOR VOTE: Third Consideration 4/9/2026

Yes: 29 • No: 0

House vote • 4/6/2026

HOUSE CALENDAR & RULES COMMITTEE

Yes: 0 • No: 0

House vote • 4/6/2026

FLOOR VOTE: REGULAR CALENDAR AS AMENDED PASSAGE ON THIRD CONSIDERATION 4/6/2026

Yes: 94 • No: 0

House vote • 3/31/2026

HOUSE HEALTH COMMITTEE

Yes: 19 • No: 0

House vote • 3/25/2026

HOUSE JUDICIARY COMMITTEE

Yes: 20 • No: 0

House vote • 3/18/2026

HOUSE CRIMINAL JUSTICE SUBCOMMITTEE

Yes: 8 • No: 0

Bill Text

  • HA0870 (Substitute)

    4/6/2026

  • Enrolled / Public Chapter

  • Fiscal Note

  • Introduced

  • SA0826

Related Bills

Back to State Legislation